Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Margin

    Back to All Ratios
AD     Remove this Ad

VALIANT LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Margin(%) -3.52-4.6210.50

What is the latest Core EBITDA Margin ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Margin ratio of VALIANT LABORATORIES is -3.52 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar2025-3.52
Mar2024-4.62
Mar202310.50

How is Core EBITDA Margin of VALIANT LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2025 -3.52
Negative
Mar2024 -4.62
Negative
Mar2023 10.5 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Margin ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹309.3 Cr -3.6% -1.5% -33.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-3.6%

-1.5%

-33.3%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses